Warning: The NCBI web site requires JavaScript to function. more...
Fetching bibliography...
Generate a file for use with external citation management software.
Nanoparticle Delivered Human Biliverdin Reductase-Based Peptide Increases Glucose Uptake by Activating IRK/Akt/GSK3 Axis: The Peptide Is Effective in the Cell and Wild-Type and Diabetic Ob/Ob Mice.
Gibbs PE, Miralem T, Lerner-Marmarosh N, Maines MD.
J Diabetes Res. 2016;2016:4712053. doi: 10.1155/2016/4712053. Epub 2016 May 17.
Similar articles
Interaction of human biliverdin reductase with Akt/protein kinase B and phosphatidylinositol-dependent kinase 1 regulates glycogen synthase kinase 3 activity: a novel mechanism of Akt activation.
Miralem T, Lerner-Marmarosh N, Gibbs PE, Jenkins JL, Heimiller C, Maines MD.
FASEB J. 2016 Aug;30(8):2926-44. doi: 10.1096/fj.201600330RR. Epub 2016 May 10.
Biliverdin reductase: a target for cancer therapy?
Gibbs PE, Miralem T, Maines MD.
Front Pharmacol. 2015 Jun 3;6:119. doi: 10.3389/fphar.2015.00119. eCollection 2015. Review.
Renal capsule xenografting and subcutaneous pellet implantation for the evaluation of prostate carcinogenesis and benign prostatic hyperplasia.
Nicholson TM, Uchtmann KS, Valdez CD, Theberge AB, Miralem T, Ricke WA.
J Vis Exp. 2013 Aug 28;(78). doi: 10.3791/50574.
The human biliverdin reductase-based peptide fragments and biliverdin regulate protein kinase Cδ activity: the peptides are inhibitors or substrate for the protein kinase C.
Miralem T, Lerner-Marmarosh N, Gibbs PE, Tudor C, Hagen FK, Maines MD.
J Biol Chem. 2012 Jul 13;287(29):24698-712. doi: 10.1074/jbc.M111.326504. Epub 2012 May 14.
Formation of ternary complex of human biliverdin reductase-protein kinase Cδ-ERK2 protein is essential for ERK2-mediated activation of Elk1 protein, nuclear factor-κB, and inducible nitric-oxidase synthase (iNOS).
Gibbs PE, Miralem T, Lerner-Marmarosh N, Tudor C, Maines MD.
J Biol Chem. 2012 Jan 6;287(2):1066-79. doi: 10.1074/jbc.M111.279612. Epub 2011 Nov 7.
Characterization of the human biliverdin reductase gene structure and regulatory elements: promoter activity is enhanced by hypoxia and suppressed by TNF-alpha-activated NF-kappaB.
FASEB J. 2010 Sep;24(9):3239-54. doi: 10.1096/fj.09-144592. Epub 2010 Apr 21.
Human biliverdin reductase suppresses Goodpasture antigen-binding protein (GPBP) kinase activity: the reductase regulates tumor necrosis factor-alpha-NF-kappaB-dependent GPBP expression.
Miralem T, Gibbs PE, Revert F, Saus J, Maines MD.
J Biol Chem. 2010 Apr 23;285(17):12551-8. doi: 10.1074/jbc.M109.032771. Epub 2010 Feb 22.
Human biliverdin reductase is an ERK activator; hBVR is an ERK nuclear transporter and is required for MAPK signaling.
Lerner-Marmarosh N, Miralem T, Gibbs PE, Maines MD.
Proc Natl Acad Sci U S A. 2008 May 13;105(19):6870-5. doi: 10.1073/pnas.0800750105. Epub 2008 May 7.
Regulation of TNF-alpha-activated PKC-zeta signaling by the human biliverdin reductase: identification of activating and inhibitory domains of the reductase.
FASEB J. 2007 Dec;21(14):3949-62. Epub 2007 Jul 17.
Human biliverdin reductase, a previously unknown activator of protein kinase C betaII.
Maines MD, Miralem T, Lerner-Marmarosh N, Shen J, Gibbs PE.
J Biol Chem. 2007 Mar 16;282(11):8110-22. Epub 2007 Jan 16.
Small interference RNA-mediated gene silencing of human biliverdin reductase, but not that of heme oxygenase-1, attenuates arsenite-mediated induction of the oxygenase and increases apoptosis in 293A kidney cells.
Miralem T, Hu Z, Torno MD, Lelli KM, Maines MD.
J Biol Chem. 2005 Apr 29;280(17):17084-92. Epub 2005 Feb 28.
Biliverdin reductase, a novel regulator for induction of activating transcription factor-2 and heme oxygenase-1.
Kravets A, Hu Z, Miralem T, Torno MD, Maines MD.
J Biol Chem. 2004 May 7;279(19):19916-23. Epub 2004 Feb 25.
Extracellular matrix enhances heregulin-dependent BRCA1 phosphorylation and suppresses BRCA1 expression through its C terminus.
Miralem T, Avraham HK.
Mol Cell Biol. 2003 Jan;23(2):579-93.
VEGF(165) requires extracellular matrix components to induce mitogenic effects and migratory response in breast cancer cells.
Miralem T, Steinberg R, Price D, Avraham H.
Oncogene. 2001 Sep 6;20(39):5511-24.
Role of vascular endothelial growth factor in the stimulation of cellular invasion and signaling of breast cancer cells.
Price DJ, Miralem T, Jiang S, Steinberg R, Avraham H.
Cell Growth Differ. 2001 Mar;12(3):129-35.
Heparan sulfate chains with antimitogenic properties arise from mesangial cell-surface proteoglycans.
Wang A, Miralem T, Templeton DM.
Metabolism. 1999 Oct;48(10):1220-9.
Inactivation of kinase cascades in mesangial cells grown on collagen type I.
Miralem T, Templeton DM.
Am J Physiol. 1998 Oct;275(4):F585-94. doi: 10.1152/ajprenal.1998.275.4.F585.
Cadmium and calcium-dependent c-fos expression in mesangial cells.
Templeton DM, Wang Z, Miralem T.
Toxicol Lett. 1998 Mar 16;95(1):1-8.
Heparin inhibits Ca2+/calmodulin-dependent kinase II activation and c-fos induction in mesangial cells.
Biochem J. 1998 Mar 1;330 ( Pt 2):651-7.
Chelation of intracellular calcium prevents mesangial cell proliferative responsiveness.
Whiteside C, Munk S, Zhou X, Miralem T, Templeton DM.
J Am Soc Nephrol. 1998 Jan;9(1):14-25.
Heparin inhibits mitogen-activated protein kinase-dependent and -independent c-fos induction in mesangial cells.
Miralem T, Wang A, Whiteside CI, Templeton DM.
J Biol Chem. 1996 Jul 19;271(29):17100-6.
Collagen type I enhances endothelin-mediated contraction and induces nonproliferating phenotype in mesangial cells.
Miralem T, Whiteside CI, Templeton DM.
Am J Physiol. 1996 Jun;270(6 Pt 2):F960-70.
Effect of aluminum chloride, -citrate, and -maltol on the calcium-mediated degradation of neurofilament proteins.
Van Ginkel MF, Heijink E, Dekker PB, Miralem T, van der Voet GB, de Wolff FA.
Neurotoxicology. 1993 Spring;14(1):13-8.
Filters: Manage Filters